{"id":231,"date":"2012-07-24T13:40:57","date_gmt":"2012-07-24T18:40:57","guid":{"rendered":"http:\/\/www.wilsonpr.com\/?p=231"},"modified":"2012-08-01T13:43:18","modified_gmt":"2012-08-01T18:43:18","slug":"advinus-therapeutics-and-p2d-bioscience-enter-into-a-research-and-development-collaboration-for-attention-deficit-hyperactivity-disorder-adhd","status":"publish","type":"post","link":"https:\/\/www.wilsonpr.com\/?p=231","title":{"rendered":"Advinus Therapeutics and P2D Bioscience Enter Into a Research and Development Collaboration for Attention Deficit Hyperactivity Disorder (ADHD)"},"content":{"rendered":"<p><a href=\"http:\/\/www.wilsonpr.com\/wp-content\/uploads\/2011\/04\/P2D-logonoline-2.jpg\"><img decoding=\"async\" loading=\"lazy\" class=\"alignleft size-medium wp-image-155\" title=\"P2D logonoline-2\" src=\"http:\/\/www.wilsonpr.com\/wp-content\/uploads\/2011\/04\/P2D-logonoline-2-300x83.jpg\" alt=\"\" width=\"300\" height=\"83\" srcset=\"https:\/\/www.wilsonpr.com\/wp-content\/uploads\/2011\/04\/P2D-logonoline-2-300x83.jpg 300w, https:\/\/www.wilsonpr.com\/wp-content\/uploads\/2011\/04\/P2D-logonoline-2.jpg 404w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a>Advinus Therapeutics Ltd., a drug discovery and development company, and\u00a0<a href=\"http:\/\/ctt.marketwire.com\/?release=912249&amp;id=1834285&amp;type=1&amp;url=http%3a%2f%2fwww.p2dinc.com%2f\">P2D Bioscience<\/a>, a CNS-focused specialty pharmaceutical company, have initiated a research and development collaboration to develop therapies for Attention Deficit Hyperactivity Disorder (ADHD).<\/p>\n<p>Visit <a href=\"http:\/\/www.marketwire.com\/press-release\/Advinus-Therapeutics-P2D-Bioscience-Enter-Into-Research-Development-Collaboration-1683103.htm\" target=\"_blank\">P2Dinc.com<\/a> to learn more.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Advinus Therapeutics Ltd., a drug discovery and development company, and\u00a0P2D Bioscience, a CNS-focused specialty pharmaceutical company, have initiated a research and development collaboration to develop therapies for Attention Deficit Hyperactivity Disorder (ADHD). Visit P2Dinc.com to learn more.<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[90,89,57],"_links":{"self":[{"href":"https:\/\/www.wilsonpr.com\/index.php?rest_route=\/wp\/v2\/posts\/231"}],"collection":[{"href":"https:\/\/www.wilsonpr.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wilsonpr.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wilsonpr.com\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wilsonpr.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=231"}],"version-history":[{"count":1,"href":"https:\/\/www.wilsonpr.com\/index.php?rest_route=\/wp\/v2\/posts\/231\/revisions"}],"predecessor-version":[{"id":232,"href":"https:\/\/www.wilsonpr.com\/index.php?rest_route=\/wp\/v2\/posts\/231\/revisions\/232"}],"wp:attachment":[{"href":"https:\/\/www.wilsonpr.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=231"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wilsonpr.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=231"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.wilsonpr.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}